SHE — Shedir Pharma Srl Unipersonale Share News
0.000.00%
Last trade - 00:00- €55.45m
- €52.75m
- €59.39m
Brief: Shedir Pharma Says Subscription Period Ends For Dimainvest Offer
Italy - Factors to watch on Jan. 10
Brief: Dimainvest Says It Reached 90% Threshold In Shedir Pharma Takeover Bid
Brief: Dimainvest Launches Takeover Bid For Shedir Pharma
Brief: Shedir Pharma H1 Net Profit At EUR 1.6 Mln
Brief: Shedir Pharma Unit Buys Business Unit From Alfasigma
Brief: Shedir Pharma FY Net Profit Down To EUR 5.7 Mln
Brief: Shedir Pharma H1 Net Profit Up To EUR 1.2 Mln
Brief: Shedir Pharma Q1 Revenue Up 44% To EUR 14.2 Mln
Brief: Shedir Pharma FY Net Profit Up To EUR 5.9 Mln
Brief: Shedir Pharma H1 Net Profit Up To EUR 1.1 Mln
Brief: Shedir Pharma H1 Prelim. Revenue From Sales Up 26% To EUR 23.3 Mln
Brief: Shedir Pharma To Start Shares Buyback Programme
Brief: Shedir Pharma Buys Again Life Group For EUR 1.2 Mln
Brief: Shedir Pharma Says New Dividend Payment Date Is Set For May 11
Brief: Shedir Pharma FY Net Profit Stable At EUR 3.9 Mln
Brief: Shedir Pharma H1 Net Profit Down At EUR 0.7 Mln
Brief: Shedir Pharma Obtains Certification As Class IIA Medical Devices For Two Product Lines
Brief: Shedir Pharma FY Net Profit Up At EUR 3.9 Mln